期刊文献+

乳腺肿瘤摄取^(99)Tc^m-甲氧基异丁基异睛与耐多药蛋白表达的关系 被引量:14

Correlation between uptake of ^(99)Tc^m-MIBI and expression of multidrug resistant protein in breast cancer
原文传递
导出
摘要 目的 研究乳腺肿瘤摄取99Tcm 甲氧基异丁基异睛 (99Tcm MIBI)与耐多药蛋白表达水平间的相关性。方法  30例经病理证实的原发性浸润性导管癌患者 ,均行99Tcm MIBI早期显像和延迟显像。对显像阳性的肿块计算感兴趣区与对侧正常相应部位的放射性计数比值 ,以早期摄取比值(EUR)和延迟摄取比值 (DUR)计算滞留指数 (RI)。以免疫组织化学法检测手术切除标本肿瘤组织的P 糖蛋白 (P gp)和多药耐药相关蛋白 (MRP)的表达水平。数据分别进行配对t检验、Pearson相关分析及偏相关分析。结果 P gp的平均表达水平为 0 .1183± 0 .0 70 0 ,MRP的平均表达水平为 0 .1195±0 .0 5 2 2。P gp和MRP的表达水平在RI≥ 0和RI <0的组中 ,差异有显著性。P gp的表达与RI(r=- 0 .919,P =0 .0 0 1)、DUR(r=- 0 .6 75 ,P =0 .0 0 1)和MRP(r=0 .5 4 9,P =0 .0 0 2 )有相关性 ,与EUR(r=- 0 .0 97,P =0 .6 10 )无相关性。MRP的表达与RI(r =- 0 .5 4 7,P =0 .0 0 2 )有相关性 ,与EUR(r=0 .2 92 ,P =0 .117)、DUR(r =- 0 .173,P =0 .36 1)无相关性。P gp与MRP的表达有相关性 (r =0 .5 4 9,P =0 .0 0 1)。偏相关分析则显示 ,P gp的表达与RI(r =- 0 .884 7,P =0 .0 0 1)有显著相关性 ,MRP的表达与RI(r=- 0 .12 96 ,P =0 .5 12 )无相关性。? Objective To assess the correlation between uptake of 99 Tc m MIBI and expression level of multidrug resistant protein in breast cancer. Methods Thirty pathologically confirmed patients with primary invasive ductal carcinoma were examined by 99 Tc m MIBI scintigraphy at 15 min and 90 min after injecting the tracer. The uptake of 99 Tc m MIBI at the region of interest (ROI) was evaluated as tumor to normal background (T/N) ratio. Retention index (RI) was calculated from the early uptake ratio (EUR) and updelayed take ratio (DUR). The expression of P glycoprotein (P gp) and multidrug resistant associated protein (MRP) was detected by immunohistochemistry and the results were expressed as optical density ( A ). The data were analyzed by t test, Pearson correlation and partial correlation analysis. Results The expression of P gp and MRP in tumor tissue was 0.1183±0.0700 and 0.1195±0.0522, respectively. In group with RI<0. the expression of P gp and MRP was 0.2181±0.0384 and 0.1718±0.0479, respectively. In group with RI≥0, the expression of P gp and MRP was 0.1057±0.0217 and 0.0967±0.0362, respectively. There were significant differences between the two groups ( t =6.61, P =0.0001; t =5.01, P =0.002). There was positive correlation between P gp and RI ( r =-0.919, P =0.001), DUR ( r =-0.675, P =0.001), MRP( r =0.549, P =0.001), respectively, but no correlation between P gp and EUR ( r =-0.097, P =0.610). There was positive correlation between MRP and RI ( r =-0.547 , P =0.002), but no correlation between MRP and EUR ( r =0.292, P =0.117) or DUR ( r =-0.173 , P =0.361). Partial correlation analysis showed that there was high positive correlation between P gp and RI( r =-0.8847, P =0.001), but no significant correlation between MRP and RI( r =-0.1296, P =0.512 ). Conclusion The study suggests that increased level of P gp expression may contribute to a low accumulation of 99 Tc m MIBI in breast cancer, but no correlation with the expression level of MRP. Thus 99 Tc m MIBI scintigraphy may predict the MDR development associated with P gp expression in breast carcinoma.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2004年第6期353-355,共3页 Chinese Journal of Oncology
关键词 乳腺肿瘤 99^Tc^m-甲氧基异丁基异睛 耐多药性 蛋白表达 P-糖蛋白 Breast neoplasms Sestamibi(MIBI) Multidrug resistance P-glycoprotein Multidrug resistant-associated protein
  • 相关文献

参考文献9

  • 1Luker GD, Fracasso PM, Dobkin J, et al. Modulation of the multidrug resistance P-glycoprotein: detection with technetium-99m-sestamibi in vivo. J Nucl Med, 1997, 38:369-372.
  • 2Schomacker K, Schicha H. Use of myocardial imaging agents for tumour diagnosis:a success story? Eur J Nucl Med, 2000, 27:1845-1863.
  • 3Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res, 1970,30:1174-1184.
  • 4Vecchio SD, Ciarmiello A, Potena MI, et al. In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients. Eur J Nucl Med, 1997,24:150-159.
  • 5Moretti JL, Duran Cordobes M, Starzec A, et al. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells. J Nucl Med, 1998,39:1214-1218.
  • 6Zhou J, Higashi K, Ueda Y, et al. Expression of multidrug resistance protein and messenger RNA correlate with (99m) Tc-MIBI imaging in patients with lung cancer.J Nucl Med, 2001,42:1476-1483.
  • 7Petrini M, Di Simone D, Favati A, et al. GST-pi and P-170 co-expression in multiple myeloma. Br J Haematol, 1995,90:393-397.
  • 8施作霖 纪小龙.诊断免疫组织化学[M].北京:军事医学科学出版社,1997.251-258.
  • 9王树滨,陈辉树,杨纯正,刘雅洁,隋广杰,李玉莲.多药耐药相关蛋白在乳腺癌组织中的表达及其与预后关系[J].临床肿瘤学杂志,2001,6(1):5-8. 被引量:5

二级参考文献8

  • 1Lehnet M, Clinical multidrugresistance resistance in cancer: a multi factorial problem. Eur J Cancer, 1996,32A:912-920.
  • 2Norris MD, Bordow SB and Marshall GM. Expression of the gene for multidrugresistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med,1996,334,231-238.
  • 3Sugawara H, Yamada H, Nakamyra H, et al. Prefential expression of the Multidrugresistace associated protein MRP in adenocarcinoma of the lung. Int J Cancer , 1995,64:322-325.
  • 4Cole SPC, Bhardaj G, Gerlach JH, et al. Overexpression of a transporter gene in amultidrug-resistant human lung cancer cell line. Science, 1992, 258:1650-1 654.
  • 5Lacave R, Coulet F, Riccl S, et al. Comparative evaluation by semiquanantita tivereverse transcriptae polymerase chain reaction of MDR1, MRP and GSTp gene expression inbreast carcinomas. Br J Cancer, 1988, 77:694-702.
  • 6Nooter K, Brutel de la Rivier G, Look MP, et al. The prognostic significance ofexpression of the multidrug resistance-associated protein(MRP) in primary br east cancer.Br J Cancer, 1997, 76: 486-493.
  • 7Beck J, Bohnet B, Brugger D, et al. Multiple gene expression analysis reveralsdistinct difference between G2 and G3 stage breast cancers, and correlation of PKC with MDR1, MRP and LRP gene expression. Br J Cancer, 1998, 77:87-91.
  • 8Filipits M., Malayeri R., Suchomel R., et al. Expression of the multidrugresistance rpotein (MRP) in breast cancer. Anticancer Res, 1999,19:5047-5050.

共引文献4

同被引文献120

引证文献14

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部